
Paul B. Manning
Founder, President, and CEO
Founder Paul Manning is the president and chief executive officer of PBM Capital Group. Before forming PBM Capital, Mr. Manning held key sales and marketing positions with leading pharmaceutical companies and founded several companies, including Able Laboratories and Manfam, Inc., two companies that developed and distributed prescription and over-the-counter products to major chains in the United States.
Aside from his entrepreneurial work, Mr. Manning and his wife, Diane Manning, founded the Focus to Cure Diabetes Foundation, which has played an integral role in establishing an islet cell transplant program at the University of Virginia (UVa). The nonprofit, volunteer organization was instrumental in helping UVa perform the state’s first islet cell transplant and continues to raise money to support diabetes research.
When it comes to diabetes, the Mannings have long put their money where their hearts are. The couple, parents of two children with type 1 diabetes, has donated several million dollars to diabetes research efforts with the aim of curing the disease.
The Mannings plan to continue funding diabetes research at UVa and have leveraged PBM Products to make progress on the diabetes research front. In fact, PBM Products introduced a line of diabetic products to help people better manage diabetes. A portion of the proceeds from the sale of the products will be donated to diabetes research.
Mr. Manning is a director of the National Neurovision Research Institute (NNRI), the clinical trial support organization of the Foundation Fighting Blindness (FFB). He is also an active member of the University of Virginia (U.Va.) Health Foundation Board of Trustees; these leaders from the private and public sectors work closely with the U.Va. Health System and the university’s leadership to foster philanthropy for the $500 million Campaign for Health.
In 2002, Mr. Manning was named Virginia Entrepreneur of the Year by Ernst & Young. He is a graduate of the University of Massachusetts, where he earned a B.S. in microbiology.

